Effect of protein kinase C activation on N-methyl-D-aspartate-evoked release of adenosine and [3H]norepinephrine from rat cortical slices

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 105-109

  Wang, Yushan ^a   White, Thomas D ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADENOSINE; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; MALE; NONHUMAN; NORADRENALIN RELEASE; PARIETAL LOBE; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; CEREBRAL CORTEX; ENZYME ACTIVATION; EXCITATORY AMINO ACID AGONISTS; INDOLES; MAGNESIUM; MALE; MALEIMIDES; N-METHYLASPARTATE; NOREPINEPHRINE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031969705     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aniksztejn L, Otani S and Ben-Ari Y (1992) Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long-term potentiation through protein kinase C, Eur J Neurosci 4:500-505.
2. Chen L and Huang LYM (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron 7:319-326.
3. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature (Lond) 356:521-523.
4. 3H]noradrenaline from rat cortical slices. Eur J Pharmacol 197:1-7
5. Craig CG and White TD (1992) Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex. J Pharmacol Exp Ther 260:1278-1284.
6. Craig CG and White TD (1993) N-methyl-d-aspartate-and non-N-methyl-d-aspartate-evoked adenosine release from rat cortical slices: Distinct purinergic sources and mechanisms of release. J Neurochem 60:1073-1080.
7. Davis PD, Elliott LH, Harris W, Hill CH, Hurst SA, Keech E, Kumar MKH, Lawton G. Nixon JS and Wilkinson SE (1992) Inhibitors of protein kinase C. 2. Substituted bisindolylmaleides with improved potency and selectivity. J Med Chem 35:994-1001
8. Gasic GP and Hollmann M (1992) Molecular neurobiology of glutamate receptors. Ann Rev Physiol 54:507-536.
9. Harvey J and Collingridge GL (1993) Signal transduction pathways involved in the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices. Br J Pharmacol 109:1085-1090.
10. 3H]norepinephrine from rat cortical slices. J Pharmacol Exp Ther 255:174-181.
11. + and glutamate-evoked release of endogenous adenosine from superfused rat cortical slices. J Neurochem 54:256-265.
12. Hollingsworth EB, Sears E and Daly JW (1985) An activator of protein kinase C (phorbol-12-myristate-13-acetate) augments 2-chloroadenosine-elicited accumulation of cyclic AMP in guinea pig cerebral cortical particulate preparations. FEBS Lett 184:339-342.
13. Kelso SR, Nelson TE and Leonard JP (1992) Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol (Lond) 449:705-718.
14. Lipton SA and Kater SB (1989) Neurotransmitter regulation of neuronal outgrowth, plasticity, and survival. Trends Neurosci 12:265-270.
15. Lipton SA and Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Eng J Med 330:613-622.
16. Manzoni OJ, Manabe T and Nicoll RA (1994) Release of adenosine by activation of NMDA receptors in the hippocampus. Science (Wash DC) 265:2098-2101.
17. Mitchell JB, Lupica CA and Dunwiddie TV (1993) Activity-dependent release of endogenous adenosine modulates synaptic responses in the rat hippocampus. J Neurosci 13:3439-3447.
18. Monaghan DT, Bridges RJ and Cotman CW (1989) The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Ann Rev Pharmac Toxic 29:365-402.
19. 2+ in mouse striatal neurons? Eur J Neurosci 6:854-860.
20. Nishizuka Y (1986) Studies and perspectives of protein kinase C. Science 233:305-312.
21. 2+ channels. J Neurochem 65: 605-614.
22. Patel AJ, Hunt A, Jacques-Berg W, Kiss J and Rodriguez J (1995) Effects of protein kinase C modulation on NMDA receptor mediated regulation of neurotransmitter enzyme and c-fos protein in cultured neurons. Neurochem Res 20:561-569.
23. 3 muscarinic receptor-mediated enhancement of NMDA-evoked adenosine release in rat cortical slices in vitro. J Neurochem 69: 1066-1072.
24. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D and Kirilovsky J (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
25. 2+-sensitivity of cloned NMDA receptors. Neuropharmacol 35:29-36.
26. White TD (1996) Potentiation of excitatory amino acid-evoked adenosine release from rat cortex by inhibitors of adenosine kinase and adenosine deaminase and by acadesine. Eur J Pharmacol 303:27-38.
27. White TD, Craig CG and Hoehn K (1993) Extracellular adenosine, formed during low level NMDA receptor activation, provides an inhibitory threshold against further NMDA receptor-mediated neurotransmission in the cortex. Drug Dev Res 28:406-409.